Although vaccine-induced GPC3-peptide-specific cytotoxic T lymphocytes (CTLs) are often tumor reactive in vitro (9) and correlate with overall survival, no complete response was observed when GPC3 peptide vaccination was used as monotherapy in patients with advanced HCC (8). Here, GPC3 is linked to hepatocellular carcinoma.